Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.266
+0.004 (1.53%)
At close: Feb 21, 2025
27.64%
Market Cap 472.27M
Revenue (ttm) n/a
Net Income (ttm) -57.70M
Shares Out 1.78B
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,992,112
Average Volume 4,174,089
Open 0.263
Previous Close 0.262
Day's Range 0.263 - 0.282
52-Week Range 0.096 - 0.576
Beta 1.39
RSI 43.62
Earnings Date Feb 27, 2025

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.